These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19648886)

  • 1. Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.
    Wei YC; Li CF; Yu SC; Chou FF; Fang FM; Eng HL; Uen YH; Tian YF; Wu JM; Li SH; Huang WW; Li WM; Huang HY
    Mod Pathol; 2009 Oct; 22(10):1351-60. PubMed ID: 19648886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.
    Li CF; Huang WW; Wu JM; Yu SC; Hu TH; Uen YH; Tian YF; Lin CN; Lu D; Fang FM; Huang HY
    Clin Cancer Res; 2008 Dec; 14(23):7822-31. PubMed ID: 19047110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs).
    Wei YC; Chou FF; Li CF; Li WM; Chen YY; Lan J; Li SH; Fang FM; Hu TH; Yu SC; Eng HL; Uen YH; Tian YF; Wang JC; Huang HY
    Histopathology; 2013 Oct; 63(4):445-54. PubMed ID: 23889148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors.
    Haller F; Happel N; Schulten HJ; von Heydebreck A; Schwager S; Armbrust T; Langer C; Gunawan B; Doenecke D; Füzesi L
    Mod Pathol; 2007 Oct; 20(10):1103-11. PubMed ID: 17673922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic reappraisal identifies MGLL overexpression as an unfavorable prognosticator in primary gastrointestinal stromal tumors.
    Li CF; Chuang IC; Liu TT; Chen KC; Chen YY; Fang FM; Li SH; Chen TJ; Yu SC; Lan J; Huang HY
    Oncotarget; 2016 Aug; 7(31):49986-49997. PubMed ID: 27366945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
    Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated T567 ezrin is associated with merlin expression in KIT-mutant gastrointestinal stromal tumors.
    Weng WH; Yeh CN; Cheng YF; Lenka G; Liaw YW
    Mol Med Rep; 2012 Jan; 5(1):17-21. PubMed ID: 21971708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
    Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
    Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival.
    Haller F; Cortis J; Helfrich J; Cameron S; Schüler P; Schwager S; Gunawan B; Füzesi L; Agaimy A
    Mod Pathol; 2011 Feb; 24(2):248-55. PubMed ID: 20834236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
    Miettinen M; Lasota J
    Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Capelli L; Petracci E; Quagliuolo V; Saragoni L; Colombo P; Morgagni P; Calistri D; Tomezzoli A; Di Cosmo M; Roviello F; Vindigni C; Coniglio A; Villanacci V; Catarci M; Coppola L; Alfieri S; Ricci R; Capella C; Rausei S; Gulino D; Amadori D; Ulivi P;
    Eur J Surg Oncol; 2016 Aug; 42(8):1206-14. PubMed ID: 27265040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
    Shen YY; Ma XL; Wang M; Zhuang C; Ni B; Tu L; Liu Q; Zhao WY; Cao H
    Cancer Med; 2020 Sep; 9(18):6485-6496. PubMed ID: 32697050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of epithelioid morphology and PDGFRA immunostaining pattern for prediction of PDGFRA mutated genotype in gastrointestinal stromal tumors (GISTs).
    Agaimy A; Otto C; Braun A; Geddert H; Schaefer IM; Haller F
    Int J Clin Exp Pathol; 2013; 6(9):1839-46. PubMed ID: 24040448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
    Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
    Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
    Peterson MR; Piao Z; Weidner N; Yi ES
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.
    Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP
    Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance.
    Boichuk S; Galembikova A; Dunaev P; Valeeva E; Shagimardanova E; Gusev O; Khaiboullina S
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29206199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.